APA (7th ed.) Citation

Taher AT, Porter JB, Kattamis A, Viprakasit V, & Cappellini MD. (2016). Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes. Dove Medical Press.

Chicago Style (17th ed.) Citation

Taher AT, Porter JB, Kattamis A, Viprakasit V, and Cappellini MD. Efficacy and Safety of Iron-chelation Therapy with Deferoxamine, Deferiprone, and Deferasirox for the Treatment of Iron-loaded Patients with Nontransfusion-dependent Thalassemia Syndromes. Dove Medical Press, 2016.

MLA (9th ed.) Citation

Taher AT, et al. Efficacy and Safety of Iron-chelation Therapy with Deferoxamine, Deferiprone, and Deferasirox for the Treatment of Iron-loaded Patients with Nontransfusion-dependent Thalassemia Syndromes. Dove Medical Press, 2016.